Market Drivers and Opportunities in U.S. Phosphoramidite Industry
The U.S. phosphoramidite market, valued at USD 393.05 million in 2024, is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2034, driven by the accelerating demand for synthetic oligonucleotides in gene therapy, CRISPR-based gene editing, and diagnostic development. Phosphoramidites—specialized chemical building blocks used in solid-phase oligonucleotide...
0 Commentaires 0 Parts 66 Vue 0 Aperçu